Lumida
/AMLX
⌘K
Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc

AMLX
$17.75USD+4.29%+0.73 today

MARKET CAP

2.0B

P/E (TTM)

FWD P/E

DAY RANGE

$17 – $18

52W RANGE

$7
$19

AI Summary

Stalk
StalkMedium

AMLX remains in a Stage 2 advancing corrective reset with clear higher highs and higher lows above rising EMAs, supporting a medium-term bullish bias. However, overbought conditions and a recent pullback into the 9- and 21-EMA zone advise patience. Execution should be deferred, stalking for acceptance and shallow pullbacks into the rising EMAs to participate in the ongoing trend.

  • Targets 160,000 US PBH patients addressing major unmet medical need
  • Phase III Lucidity trial completes in Q3 2026, paving FDA NDA submission
  • Q1 2026 EPS loss $0.37 misses consensus $0.33 target
Full analysis →
Insider Trades64 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 9, 2026SellAMLXGina MazzarielloChief Legal Officer30,000$17.96$2.0B-7.31%+137.30%$538.9K-7.44%10b5-1Buy Now
Mar 2, 2026SellAMLXCamille L BedrosianChief Medical Officer6,461$14.58$2.0B-7.31%+137.30%$94.2K-3.68%Buy Now
Mar 2, 2026SellAMLXGina MazzarielloChief Legal Officer6,844$14.52$2.0B-7.31%+137.30%$99.4K-4.84%Buy Now
Mar 2, 2026SellAMLXJames M FratesChief Financial Officer7,909$14.52$2.0B-7.31%+137.30%$114.9K-4.56%Buy Now
Mar 2, 2026SellAMLXJustin B. KleeCo-Chief Executive Officer29,282$14.47$2.0B-7.31%+137.30%$423.8K-0.87%Buy Now
Mar 2, 2026SellAMLXJoshua B CohenCo-Chief Executive Officer29,282$14.48$2.0B-7.31%+137.30%$424.1K-0.87%Buy Now
Feb 23, 2026SellAMLXGina MazzarielloChief Legal Officer3,419$14.14$2.0B-7.31%+137.30%$48.4K-2.36%Buy Now
Feb 2, 2026SellAMLXGina MazzarielloChief Legal Officer3,448$14.65$2.0B-7.31%+137.30%$50.5K-2.33%Buy Now
Feb 2, 2026SellAMLXJames M FratesChief Financial Officer3,557$14.65$2.0B-7.31%+137.30%$52.1K-2.01%Buy Now
Feb 2, 2026SellAMLXJoshua B CohenCo-Chief Executive Officer15,500$14.68$2.0B-7.31%+137.30%$227.6K-0.46%Buy Now
Feb 2, 2026SellAMLXJustin B. KleeCo-Chief Executive Officer15,500$14.69$2.0B-7.31%+137.30%$227.6K-0.46%Buy Now
Jan 15, 2026BuyAMLXJustin B. KleeCo-Chief Executive Officer338,188$10.03$2.0B-7.31%+137.30%$3.4M+0.45%Buy Now
Jan 15, 2026BuyAMLXJoshua B CohenCo-Chief Executive Officer338,167$10.03$2.0B-7.31%+137.30%$3.4M+0.45%Buy Now
Jan 6, 2026SellAMLXJames M FratesChief Financial Officer3,326$11.11$2.0B-7.31%+137.30%$37.0K-1.84%Buy Now
Jan 6, 2026SellAMLXJustin B. KleeCo-Chief Executive Officer7,715$11.09$2.0B-7.31%+137.30%$85.6K-0.23%Buy Now
Jan 6, 2026SellAMLXJoshua B CohenCo-Chief Executive Officer7,715$11.09$2.0B-7.31%+137.30%$85.6K-0.23%Buy Now
Dec 1, 2025SellAMLXCamille L BedrosianChief Medical Officer6,580$14.35$2.0B-7.31%+137.30%$94.4K-3.61%Buy Now
Sep 30, 2025SellAMLXGina MazzarielloChief Legal Officer8,828$14.58$2.0B-7.31%+137.30%$128.7K-5.62%Buy Now
Sep 30, 2025SellAMLXJames M FratesChief Financial Officer10,558$14.65$2.0B-7.31%+137.30%$154.7K-3.63%Buy Now
Sep 30, 2025SellAMLXCamille L BedrosianChief Medical Officer12,039$14.58$2.0B-7.31%+137.30%$175.5K-6.19%Buy Now
Sep 30, 2025SellAMLXJoshua B CohenCo-Chief Executive Officer29,933$14.35$2.0B-7.31%+137.30%$429.5K-0.45%Buy Now
Sep 30, 2025SellAMLXJustin B. KleeCo-Chief Executive Officer29,975$14.38$2.0B-7.31%+137.30%$431.0K-0.45%Buy Now
Aug 12, 2025SellAMLXGina MazzarielloChief Legal Officer30,000$8.20$2.0B-7.31%+137.30%$246.1K-8.36%10b5-1Buy Now
May 22, 2025SellAMLXGina MazzarielloChief Legal Officer1,000$5.36$2.0B-7.31%+137.30%$5.4K-0.53%Buy Now
Mar 31, 2025SellAMLXGina MazzarielloChief Legal Officer9,192$3.48$2.0B-7.31%+137.30%$32.0K-4.66%Buy Now
Mar 31, 2025SellAMLXJames M FratesChief Financial Officer10,896$3.47$2.0B-7.31%+137.30%$37.8K-3.61%Buy Now
Mar 31, 2025SellAMLXCamille L BedrosianChief Medical Officer12,425$3.47$2.0B-7.31%+137.30%$43.1K-6.01%Buy Now
Mar 31, 2025SellAMLXJustin B. KleeCo-Chief Executive Officer21,490$3.46$2.0B-7.31%+137.30%$74.5K-0.64%Buy Now
Mar 31, 2025SellAMLXJoshua B CohenCo-Chief Executive Officer21,490$3.47$2.0B-7.31%+137.30%$74.5K-0.64%Buy Now
Mar 3, 2025SellAMLXGina MazzarielloChief Legal Officer1,611$3.12$2.0B-7.31%+137.30%$5.0K-1.19%Buy Now
Mar 3, 2025SellAMLXJustin B. KleeCo-Chief Executive Officer4,595$3.15$2.0B-7.31%+137.30%$14.5K-0.14%Buy Now
Mar 3, 2025SellAMLXJoshua B CohenCo-Chief Executive Officer4,595$3.17$2.0B-7.31%+137.30%$14.5K-0.14%Buy Now
Feb 24, 2025SellAMLXGina MazzarielloChief Legal Officer4,169$3.15$2.0B-7.31%+137.30%$13.1K-3.00%Buy Now
Feb 5, 2025BuyAMLXJustin B. KleeCo-Chief Executive Officer36,310$1.57$2.0B-7.31%+137.30%$57.0K+1.15%Buy Now
Feb 3, 2025SellAMLXGina MazzarielloChief Legal Officer3,678$3.49$2.0B-7.31%+137.30%$12.8K-2.58%Buy Now
Feb 3, 2025SellAMLXJustin B. KleeCo-Chief Executive Officer11,855$3.47$2.0B-7.31%+137.30%$41.1K-0.37%Buy Now
Feb 3, 2025SellAMLXJoshua B CohenCo-Chief Executive Officer11,851$3.47$2.0B-7.31%+137.30%$41.1K-0.37%Buy Now
Jan 6, 2025SellAMLXJustin B. KleeCo-Chief Executive Officer7,471$4.04$2.0B-7.31%+137.30%$30.2K-0.23%Buy Now
Jan 6, 2025SellAMLXJoshua B CohenCo-Chief Executive Officer7,471$4.05$2.0B-7.31%+137.30%$30.2K-0.23%Buy Now
Dec 2, 2024SellAMLXCamille L BedrosianChief Medical Officer5,421$5.54$2.0B-7.31%+137.30%$30.0K-3.77%Buy Now
Nov 4, 2024BuyAMLXJustin B. KleeCo-Chief Executive Officer63,690$1.57$2.0B-7.31%+137.30%$100.0K+2.02%Buy Now
Sep 30, 2024SellAMLXGina MazzarielloChief Legal Officer8,709$3.20$2.0B-7.31%+137.30%$27.8K-5.75%Buy Now
Sep 30, 2024SellAMLXCamille L BedrosianChief Medical Officer11,442$3.20$2.0B-7.31%+137.30%$36.6K-7.37%Buy Now
Sep 30, 2024SellAMLXJoshua B CohenCo-Chief Executive Officer18,589$3.20$2.0B-7.31%+137.30%$59.4K-0.57%Buy Now
Sep 30, 2024SellAMLXJustin B. KleeCo-Chief Executive Officer18,589$3.20$2.0B-7.31%+137.30%$59.4K-0.59%Buy Now
Sep 23, 2024BuyAMLXJoshua B CohenCo-Chief Executive Officer1,857$1.57$2.0B-7.31%+137.30%$2.9K+0.06%Buy Now
Sep 12, 2024BuyAMLXJoshua B CohenCo-Chief Executive Officer34,449$1.57$2.0B-7.31%+137.30%$54.1K+1.07%Buy Now
Sep 12, 2024BuyAMLXJames M FratesChief Financial Officer40,000$2.53$2.0B-7.31%+137.30%$101.4K+20.68%Buy Now
May 15, 2024SellAMLXGina MazzarielloChief Legal Officer10,455$1.88$2.0B-7.31%+137.30%$19.7K-6.46%10b5-1Buy Now
Mar 5, 2024SellAMLXGina MazzarielloChief Legal Officer1,540$18.73$2.0B-7.31%+137.30%$28.8K-1.86%Buy Now
Mar 5, 2024SellAMLXJames M FratesChief Financial Officer1,792$18.73$2.0B-7.31%+137.30%$33.6K-1.31%Buy Now
Mar 5, 2024SellAMLXJustin B. KleeCo-Chief Executive Officer4,135$18.73$2.0B-7.31%+137.30%$77.4K-0.14%Buy Now
Mar 5, 2024SellAMLXJoshua B CohenCo-Chief Executive Officer4,135$18.73$2.0B-7.31%+137.30%$77.4K-0.14%Buy Now
Feb 23, 2024SellAMLXGina MazzarielloChief Legal Officer2,838$18.76$2.0B-7.31%+137.30%$53.2K-5.78%Buy Now
Jan 9, 2024SellAMLXJames M FratesChief Financial Officer2,716$16.33$2.0B-7.31%+137.30%$44.3K-2.37%Buy Now
Jan 9, 2024SellAMLXPatrick D YeramianChief Medical Officer2,812$16.33$2.0B-7.31%+137.30%$45.9K-1.35%Buy Now
Jan 9, 2024SellAMLXJoshua B CohenCo-Chief Executive Officer5,841$16.33$2.0B-7.31%+137.30%$95.4K-0.20%Buy Now
Jan 9, 2024SellAMLXJustin B. KleeCo-Chief Executive Officer5,841$16.33$2.0B-7.31%+137.30%$95.4K-0.21%Buy Now
Dec 27, 2023BuyAMLXMargaret OlingerChief Commercial Officer25,000$0.37$2.0B-7.31%+137.30%$9.3K+8.45%Buy Now
Nov 16, 2023BuyAMLXJoshua B CohenCo-Chief Executive Officer63,694$1.57$2.0B-7.31%+137.30%$100.0K+2.21%Buy Now
Oct 31, 2023BuyAMLXJames M FratesChief Financial Officer11,072$16.31$2.0B-7.31%+137.30%$180.6KBuy Now
Aug 23, 2023BuyAMLXJames M FratesChief Financial Officer18,165$6.88$2.0B-7.31%+137.30%$125.0K+4.02%Buy Now
Aug 23, 2023BuyAMLXJames M FratesChief Financial Officer18,165$6.88$2.0B-7.31%+137.30%$125.0K+4.33%Buy Now
Aug 15, 2023SellAMLXGina MazzarielloChief Legal Officer6,164$20.88$2.0B-7.31%+137.30%$128.7K-11.16%10b5-1Buy Now